VOLIBO R 0.3/1

VOLIBO R 0.3/1 is a medication often used to help manage blood sugar levels in people with type 2 diabetes. This combination therapy supports patients in maintaining a healthier lifestyle by assisting their body in processing sugars more effectively. By combining two active ingredients, Repaglinide and Voglibose, this product aims to provide a balanced approach to controlling post-meal blood sugar spikes.

Repaglinide works by encouraging the pancreas to release insulin when blood sugar levels rise, particularly after eating. Voglibose, on the other hand, slows down the digestion of carbohydrates in the gut, helping to reduce the amount of sugar entering the bloodstream. Together, they can help patients achieve a more stable glucose level throughout the day.

For optimal effectiveness, it is important to store VOLIBO R 0.3/1 in a cool, dry place away from direct sunlight. Consistency in use is key, and patients are encouraged to follow their healthcare provider’s recommendations regarding lifestyle and dietary choices alongside this medication. Individuals should also be aware of general precautions, such as monitoring for blood sugar levels regularly.

Common side effects may include mild gastrointestinal issues, such as gas, bloating, or diarrhea. These effects are generally temporary and may decrease as the body adjusts to the medication.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.